Metastatic Carcinoma and Myeloma of the Femur
RECOMMENDATIONS
Imaging and Clinical Findings
Efficacy of Bone Modifying Agents (BMAs)
Dosage Response of BMAs
BMAs for Various Diagnoses
Imaging Findings and Atypical Fractures
Efficacy of Radiation Therapy
Radiation Therapy and Prophylactic Femur Stabilization
Radiation Therapy after Resection and Reconstruction
Multi-Fraction Radiation Treatment
Estimating Survival and Reconstruction Method
Long Stem Hemiarthroplasty
Cephalomedullary Nailing
Arthroplasty
Recommendation Grading
Overview
Title
Treatment of Metastatic Carcinoma and Myeloma of the Femur
Authoring Organizations
American Society for Radiation Oncology
American Society of Clinical Oncology
Musculoskeletal Tumor Society
Publication Month/Year
October 1, 2020
Last Updated Month/Year
April 1, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Target Patient Population
Patients with metastatic or myelomatous lesions of the femur regardless of age, sex, race, ethnicity, education, or socioeconomic status
Target Provider Population
Orthopaedic surgeons, oncologists, radiation oncologists and primary care physicians
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Infant, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient, Radiology services, Operating and recovery room
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening
Diseases/Conditions (MeSH)
D001859 - Bone Neoplasms, D009140 - Musculoskeletal Diseases
Keywords
musculoskeletal tumor, orthopaedic oncology, myelomatous lesions